These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30690891)
1. Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection. An S; Tiruthani K; Wang Y; Xu L; Hu M; Li J; Song W; Jiang H; Sun J; Liu R; Huang L Small; 2019 Mar; 15(9):e1805182. PubMed ID: 30690891 [TBL] [Abstract][Full Text] [Related]
2. CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis. Wu J; Li L; Liu J; Wang Y; Wang Z; Wang Y; Liu W; Zhou Z; Chen C; Liu R; Yang R Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):835-842. PubMed ID: 30032244 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel treatment enhances lymphatic metastasis of B16F10 melanoma cells via CCL21/CCR7 axis. Zhang L; Zhu L; Yao X; Lou X; Wan J; Duan X; Pan L; Li A; Gu Z; Wang M; Wang F; Qin Z Int J Biol Sci; 2022; 18(4):1476-1490. PubMed ID: 35280672 [TBL] [Abstract][Full Text] [Related]
4. High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer. Li X; Sun S; Li N; Gao J; Yu J; Zhao J; Li M; Zhao Z Cell Physiol Biochem; 2017; 43(2):531-539. PubMed ID: 28930757 [TBL] [Abstract][Full Text] [Related]
5. Lymphatic Metastasis of NSCLC Involves Chemotaxis Effects of Lymphatic Endothelial Cells through the CCR7-CCL21 Axis Modulated by TNF-α. Zhang S; Wang H; Xu Z; Bai Y; Xu L Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33158173 [TBL] [Abstract][Full Text] [Related]
6. Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer. Huang HL; Chiang CH; Hung WC; Hou MF Oncotarget; 2015 Jan; 6(2):995-1007. PubMed ID: 25557171 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis. Jin K; Pandey NB; Popel AS Breast Cancer Res; 2018 Jun; 20(1):54. PubMed ID: 29898755 [TBL] [Abstract][Full Text] [Related]
8. Site-Specific Polyplex on CCR7 Down-Regulation and T Cell Elevation for Lymphatic Metastasis Blocking on Breast Cancer. Deng Y; Tan C; Huang S; Sun H; Li Z; Li J; Zhou Z; Sun M Adv Healthc Mater; 2022 Nov; 11(22):e2201166. PubMed ID: 36113849 [TBL] [Abstract][Full Text] [Related]
9. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Pang MF; Georgoudaki AM; Lambut L; Johansson J; Tabor V; Hagikura K; Jin Y; Jansson M; Alexander JS; Nelson CM; Jakobsson L; Betsholtz C; Sund M; Karlsson MC; Fuxe J Oncogene; 2016 Feb; 35(6):748-60. PubMed ID: 25961925 [TBL] [Abstract][Full Text] [Related]
10. MiR-let-7a/f-CCR7 signaling is involved in the anti-metastatic effects of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos in melanoma. Liu YX; Bai JX; Li T; Fu XQ; Chen YJ; Zhu PL; Chou JY; Yin CL; Li JK; Wang YP; Wu JY; Yu ZL Phytomedicine; 2019 Nov; 64():153084. PubMed ID: 31514083 [TBL] [Abstract][Full Text] [Related]
11. CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the "ERK1/2 - AP-1" and "JNK - AP-1" pathways. Hong H; He C; Zhu S; Zhang Y; Wang X; She F; Chen Y J Exp Clin Cancer Res; 2016 Mar; 35():51. PubMed ID: 27009073 [TBL] [Abstract][Full Text] [Related]
12. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors. Weitzenfeld P; Kossover O; Körner C; Meshel T; Wiemann S; Seliktar D; Legler DF; Ben-Baruch A J Leukoc Biol; 2016 Jun; 99(6):1009-25. PubMed ID: 26936935 [TBL] [Abstract][Full Text] [Related]
13. Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models. Salembier R; De Haes C; Bellemans J; Demeyere K; Van Den Broeck W; Sanders NN; Van Laere S; Lyons TR; Meyer E; Steenbrugge J Breast Cancer Res; 2024 Apr; 26(1):63. PubMed ID: 38605414 [TBL] [Abstract][Full Text] [Related]
14. [Progress in targeting therapy of cancer metastasis by CCL21/CCR7 axis]. Zhang L; Wang F; Yao X; Ma S; Zhang L; Qin Z Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2741-2754. PubMed ID: 33398969 [TBL] [Abstract][Full Text] [Related]
15. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels. Hayasaka H; Yoshida J; Kuroda Y; Nishiguchi A; Matsusaki M; Kishimoto K; Nishimura H; Okada M; Shimomura Y; Kobayashi D; Shimazu Y; Taya Y; Akashi M; Miyasaka M Cancer Sci; 2022 Apr; 113(4):1338-1351. PubMed ID: 35133060 [TBL] [Abstract][Full Text] [Related]
16. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway. Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957 [TBL] [Abstract][Full Text] [Related]